Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-017884

CEO and President gave up 6,088 shares (to pay taxes)

  • CEO and President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-16 Exercise or conversion : show line 1 in the form +25,000 434,890 D
2023-06-16 Shares withheld for taxes : show line 2 in the form −6,088 $0.57 $3,470 428,802 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −25,000 1,072,941 D
Loading xslF345X04/rdgdoc.xml…